ULTRALIFE CORP Financial Summary

Quick Answer

ULTRALIFE CORP reported Total Revenue of $85.53 million for fiscal year 2017.

ULTRALIFE CORP — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue
Net Income -$5.90M
-193.4%
$6.31M
-12.3%
$7.20M
+6147.9%
-$119.0K
+49.1%
-$234.0K
-104.5%
$5.23M
+0.5%
Diluted EPS -$35.00
-192.1%
$38.00
+8536.4%
$0.44
+780.0%
$0.05
+0.0%
$0.05
-84.8%
$0.33
-99.0%
Total Assets $216.91M
-1.6%
$220.45M
+23.7%
$178.28M
+5.8%
$168.43M
+5.6%
$159.54M
+15.9%
$137.70M
-4.7%
Cash and Equivalents
Long-Term Debt $45.53M
-11.6%
$51.50M
+118.0%
$23.62M
+22.3%
$19.31M
+2.4%
$18.86M $0.00
-100.0%
Stockholders Equity $130.00M
-3.0%
$134.00M
+6.9%
$125.33M
+7.8%
$116.28M
-1.1%
$117.62M
+0.7%
$116.80M
+6.4%
R&D Expense $10.40M
+25.8%
$8.27M
+9.8%
$7.53M
+6.4%
$7.08M
+3.7%
$6.83M
+14.8%
$5.95M
-12.6%
Operating Income -$5.90M
-159.2%
$9.96M
+5.2%
$9.47M
+7245.0%
$129.0K
+268.6%
$35.0K
-99.4%
$5.70M
-22.6%
Gross Profit $46.02M
+8.8%
$42.31M
+7.9%
$39.20M
+33.3%
$29.40M
+19.3%
$24.64M
-15.5%
$29.16M
-6.4%
Shares Outstanding 16.66M
+0.1%
16.63M
+1.7%
16.35M
+0.0%
16.35M
+1.3%
16.14M
+1.1%
15.96M
+0.6%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2017 $21.05M +7.2% +5.6%
Net Income September 30, 2025 -$1.22M -572.9% -238.8%
Diluted EPS September 30, 2025 -$0.07 -450.0% -240.0%
Total Assets September 30, 2025 $222.25M +28.9% +0.6%
Cash and Equivalents September 30, 2016 $6.65M -54.4% +113.1%
Long-Term Debt September 30, 2025 $46.52M +690.0% -2.1%
Stockholders Equity September 30, 2025 $137.26M +2.1% -0.9%
R&D Expense September 30, 2025 $2.85M +35.9% +23.2%
Operating Income September 30, 2025 -$951.0K -286.1% -142.2%
Gross Profit September 30, 2025 $9.62M +10.8% -17.1%
Shares Outstanding September 30, 2025 16.65M +0.1% +0.0%
  • ULTRALIFE CORP reported Total Revenue of $85.53 million for fiscal year 2017.
  • ULTRALIFE CORP showed an increase of +3.7% in Total Revenue compared to the prior fiscal year.
  • ULTRALIFE CORP reported Net Income of -$5.90 million for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -193.4% in Net Income compared to the prior fiscal year.
  • ULTRALIFE CORP reported Diluted EPS of $35.00 per share (loss) for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -192.1% in Diluted EPS compared to the prior fiscal year.
  • ULTRALIFE CORP reported Total Assets of $216.91 million for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -1.6% in Total Assets compared to the prior fiscal year.
  • ULTRALIFE CORP reported Cash and Equivalents of $14.39 million for fiscal year 2015.
  • ULTRALIFE CORP showed a decrease of -18.7% in Cash and Equivalents compared to the prior fiscal year.
  • ULTRALIFE CORP reported Long-Term Debt of $45.53 million for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -11.6% in Long-Term Debt compared to the prior fiscal year.
  • ULTRALIFE CORP reported Stockholders Equity of $130.00 million for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -3.0% in Stockholders Equity compared to the prior fiscal year.
  • ULTRALIFE CORP reported R&D Expense of $10.40 million for fiscal year 2025.
  • ULTRALIFE CORP showed an increase of +25.8% in R&D Expense compared to the prior fiscal year.
  • ULTRALIFE CORP reported Operating Income of -$5.90 million for fiscal year 2025.
  • ULTRALIFE CORP showed a decrease of -159.2% in Operating Income compared to the prior fiscal year.
  • ULTRALIFE CORP reported Gross Profit of $46.02 million for fiscal year 2025.
  • ULTRALIFE CORP showed an increase of +8.8% in Gross Profit compared to the prior fiscal year.
  • ULTRALIFE CORP reported Shares Outstanding of 16.66 million shares for fiscal year 2025.
  • ULTRALIFE CORP showed an increase of +0.1% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment